We are live on ! Find out more
GCM

Goldman Capital Management Portfolio holdings

AUM $103M
1-Year Est. Return 21.37%
This Fund
S&P 500
This Quarter Est. Return
+15.49%
1 Year Est. Return
+21.37%
3 Year Est. Return
+24.28%
5 Year Est. Return
10 Year Est. Return
AUM
$151M
AUM Growth
-$23.9M
Cap. Flow
-$11.2M
Cap. Flow %
-7.42%
Top 10 Hldgs %
78.85%
Holding
36
New
2
Increased
9
Reduced
16
Closed
8

Sector Composition

Rank Sector Weight
1 Technology 19.01%
2 Communication Services 8.93%
3 Consumer Discretionary 6.99%
4 Healthcare 6.26%
5 Energy 2.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IW
1
DELISTED
IMAGEWARE SYSTEMS,INC
IW
$47.7M 31.52%
30,023,578
+235,000
+0.8% +$374K
HILL
2
DELISTED
DOT HILL SYSTEMS CORP
HILL
$12.3M 8.11%
5,740,294
+348,480
+6% +$853K
STGW icon
3
Stagwell
STGW
$1.84B
$11.7M 7.69%
624,621
-57,123
-8% -$890K
TRAK icon
4
ReposiTrak
TRAK
$148M
$9.65M 6.37%
1,105,854
-299,000
-21% -$2.32M
STSI
5
DELISTED
STAR SCIENTIFIC INC
STSI
$9.08M 6%
4,753,697
+341,000
+8% +$646K
LCUT icon
6
Lifetime Brands
LCUT
$199M
$7M 4.62%
457,756
-73,800
-14% -$1.06M
TRIB
7
Trinity Biotech
TRIB
$5.7M
$6.79M 4.48%
2,080
-207
-9% -$605K
LOCM
8
DELISTED
LOCAL CORP COM STK (DE)
LOCM
$5.5M 3.63%
2,818,473
+548,973
+24% +$944K
REFR icon
9
Research Frontiers
REFR
$16.1M
$5.12M 3.38%
1,208,000
+142,000
+13% +$592K
FCRE
10
DELISTED
FC Global Realty Incorporated Common Stock
FCRE
$4.61M 3.04%
57,933
-20,840
-26% -$1.65M
ACTA
11
DELISTED
Actua Corp
ACTA
$4.4M 2.9%
310,000
-87,500
-22% -$1.12M
PRSO icon
12
Peraso
PRSO
$10.3M
$4.3M 2.84%
145
+39
+37% +$1.21M
CTHR
13
DELISTED
Charles & Colvard Ltd
CTHR
$3.58M 2.37%
51,122
-32,058
-39% -$2.01M
MATR
14
DELISTED
Mattersight Corp.
MATR
$3.15M 2.08%
832,000
+572,000
+220% +$1.99M
WLB
15
DELISTED
Westmoreland Coal Company
WLB
$3.09M 2.04%
234,666
-44,401
-16% -$569K
CYRN
16
DELISTED
CYREN Ltd.
CYRN
$2.58M 1.7%
48,000
+50
+0.1% +$2.78K
III icon
17
Information Services Group
III
$185M
$2.07M 1.37%
500,700
-354,106
-41% -$1.11M
CXDO icon
18
Crexendo
CXDO
$215M
$1.88M 1.24%
624,296
-13,007
-2% -$40.1K
XTNT icon
19
Xtant Medical Holdings
XTNT
$60.1M
$1.68M 1.11%
20,866
+1,007
+5% +$72.3K
PFSW
20
DELISTED
PFSweb, Inc.
PFSW
$1.16M 0.76%
193,999
-104,001
-35% -$487K
PSTV icon
21
Plus Therapeutics
PSTV
$26.4M
0
PRKR
22
DELISTED
Parkervision Inc
PRKR
$503K 0.33%
15,000
-9,500
-39% -$380K
TBIO
23
DELISTED
TRANGSGENOMIC INC
TBIO
$169K 0.11%
445,500
-504,500
-53% -$191K
NVMI
24
Nova
NVMI
$13.9B
$160K 0.11%
18,000
-26,539
-60% -$237K
CASM
25
DELISTED
CAS Medical Systems, Inc.
CASM
$113K 0.07%
+84,030
New +$123K

Similar funds

Goldman Capital Management's Q3 2013 Portfolio in Review

As of Q3 2013, Goldman Capital Management held 36 positions worth $151M, down 14% from $175M the previous quarter. Its ten largest holdings account for 79% of the portfolio.

Goldman Capital Management withdrew a net $11.2M in Q3 2013, closing 8 positions and reducing 16 holdings. Its most notable exit was COLUMBIA LABORATORIE INC, an estimated $2.05M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, Goldman Capital Management opened a new position in CAS Medical Systems, Inc. worth $113K.

  • Goldman Capital Management's largest Q3 2013 buy was CAS Medical Systems, Inc.: 84,030 shares worth $113K.
  • Goldman Capital Management added most to Mattersight Corp. in Q3 2013, an estimated $1.99M increase.
  • Goldman Capital Management's biggest Q3 2013 reduction was ReposiTrak, cutting an estimated $2.32M.
  • Goldman Capital Management fully exited COLUMBIA LABORATORIE INC in Q3 2013, selling an estimated $2.05M.
  • Goldman Capital Management's ten largest holdings make up 79% of its $151M portfolio in Q3 2013.
  • Goldman Capital Management opened 2 new positions and closed 8 in Q3 2013.
  • Goldman Capital Management's portfolio value fell 14% quarter-over-quarter to $151M.

Based on Goldman Capital Management's 13F filing for Q3 2013, filed 15 Nov 2013.